BioSpace News Archive

The date and time of the 2020 Annual Meeting remain 8:30 a.m. ET on June 17, 2020 – – To participate in the virtual meeting, stockholders must register by 11:59 ET on June 15, 2020 –

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Follica, Inc. announced positive feedback from a meeting with the U.S. Food and Drug Administration as the company prepares to advance its lead program into Phase 3 development following a successful safety and efficacy optimization study for the treatment of hair loss in male androgenetic alopecia announced in December 2019.

First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH

Alexion Pharmaceuticals announced that management will present at the 41st Annual Global Goldman Sachs Healthcare Conference, taking place virtually on Tuesday, June 9th, 2020 at 1:20 p.m. ET.

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, will participate in two upcoming investor conferences

Prevail Therapeutics Inc., a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, announced the appointment of Kira Schwartz, J.D., as the Company’s General Counsel.

Yuva Biosciences, an anti-aging startup based on technology developed by one of the world leaders in mitochondrial sciences, Dr. Keshav K. Singh, is pleased to announce that Dr. Singh joined the Science of AgingSM faculty, a platform owned and run by Allergan Aesthetics Medicine R&D.

Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disorders

Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million.